C
CytomX Therapeutics, Inc.
CTMXHealth Care· South San Francisco, California, United States
LAYOFFS TRACKED
2
LAST EVENT
Jan 17, 2025
MARKET CAP
$723.43M
as of Aug 26, 2026
EMPLOYEES
147
CytomX Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing conditionally activated therapeutics, including Probody drug candidates that are designed to be activated in the tumor microenvironment. The company develops antibody-based therapies for oncology and immunology indications, often in collaboration with larger pharmaceutical partners.
Layoff history
EMPLOYEES AFFECTED PER QUARTER · HOVER FOR DETAILS
66
46
Q3 '22Q1 '23Q1 '24Q1 '25Q1 '26Q3 '26
Layoff timeline
2 EVENTSStories from here
No one has shared a story from CytomX yet. Went through a layoff here? Your experience helps others feel less alone.
Share your story →Get alerts for CytomX
We'll email you the moment a new layoff is reported here.